In addition to our internal team of experts, Alcon collaborates with medical innovators, research advisors, and academic thought leaders around the world to further drive innovation and advance our R&D capabilities. Alcon seeks to build and sustain strong partnerships with the brightest innovators aligned with our mission, and many of our successful programs are the result of these ongoing, collaborative relationships.
The Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization for Novartis, committed to discovering innovative medicines that treat disease and improve human health. As part of Novartis, Alcon leverages the capabilities and resources of NIBR to accelerate innovation for the eye.
For Alcon’s pharmaceutical business, NIBR engages in research activities in an effort to expand ophthalmic research targets, with a particular focus on diseases such as glaucoma and macular degeneration.
The Alcon Research Council is an advisory board consisting of the world’s key academic thought leaders in ophthalmology, which helps to validate Alcon’s research pipeline strategy.
Alcon maintains strong relationships with leading academic centers in basic and applied sciences, enabling us access to researchers, professors, pre-clinical and clinical advisors, and potential employees.